CXCL12 and B-cell non-Hodgkin lymphoma: Because B cell lymphomas are enriched for CXCL12-expressing stromal cells (45), it was possible that the greater efficacy of allo-TCXCR4 in comparison with controls could be linked directly to their increased recruitment to the tumor bed.